摘要：

The invention disclosed herein relates to novel unit dosage compositions comprising 0.1 to 10.0 grams of quaternary poly[(alkylimino)alkylene] linear polymers free from cross-linking, which compositions are valuable as bile acid binding agents; and the invention also relates to the method of binding bile acids by orally administering such compositions.

展开